• All
  • About us
  • Campaigning
  • Dementia info
  • Fundraising
  • Living with dementia
  • Our scientists
  • Our supporters
  • Research
IMAGE CREDIT: Katherine Kopeikina and Tara Spires-Jones

Untangling frontotemporal dementia

Dementia is thought to affect around 850,000 people in the UK. Most people associate the condition with Alzheimer’s disease, the most common cause of dementia. But there are other diseases that can cause the symptoms of dementia – including frontotemporal dementia (FTD).


You’ll feel tickety-boo with Tikiboo!

Have you heard the news about the partnership between Alzheimer’s Research UK and Tikiboo?

I’m helping Alzheimer’s Research UK from home, and you can too.

With social fundraising no longer an option, my new working from home environment meant that I had to find a different way to help, and that was to learn more about dementia.


Hidden beauty, fascinating insights

Microscopic images reveal the hidden beauty around and within us. Dementia researchers get a unique view of the intricate but stunning workings of the brain. To showcase the fascinating insights being gained in dementia research, we ran our Science Image Competition again this year.

Alzheimer’s Research UK supports tracking COVID-19 symptoms with new app

The COVID-19 Symptom Tracker app, developed by King’s College London, is joining forces with the UK’s largest health-based charities. The aim is to reach people most at risk of COVID-19, including those with pre-existing health conditions such as dementia, diabetes, heart disease and those over the age of 70.

Fundraising during a national crisis

You may take comfort in knowing that previous generations have found innovative ways to raise money for charity in the face of international crisis.


Running alone but supporting dementia research together

It’s been great to hear supporters viewing the postponement of their event as an opportunity to use the time to raise even more money for dementia research and smash their fundraising targets. It’s brilliant to know our supporters are finding a way to continue to support our work in these extraordinary times.


A glimmer of hope for an Alzheimer’s drug? What’s new with DIAN-TU?

This latest data offers a glimmer of hope for gantenerumab. The decrease in protein levels has led the researchers and the pharmaceutical company Roche to now invite the participants to take part in an open-label extension.

Types of dementia 2023

Vascular dementia explained

Although Alzheimer’s is the leading cause of dementia, vascular dementia affects 150,000 people in the UK, accounting for one in five of all dementia cases.


Research finds a way – our virtual conference showed it is possible

We hatched a plan to make sure that this year’s conference went ahead, but safely in light of the current coronavirus outbreak. It led to a huge social media effort to recreate the conference virtually on Twitter.

Positive lifestyle changes to help reduce the risk of developing dementia

We’re thrilled to announce that we’re partnering with Alzheimer’s Research UK, one of the world’s leading dementia research charities dedicated to diagnosis, prevention, treatment and cure.


“It’s the highlight of my career so far – I called my mum as soon as I found out”

Amy Lloyd wins the 2020 award, which would ordinarily have been presented at our annual Research Conference that was due to take place in Wales this month.

COVID-19 – The dementia research field adapts

People with dementia are likely to be particularly vulnerable to this virus so it is especially important that they and those around them take what steps they can to avoid transmission.

COVID-19: A message for our supporters

We’re acutely aware of the impact the outbreak will be having on people with dementia and their families, exacerbating an already unprecedented situation. Our hearts go out to everyone in such circumstances.


Rare causes of dementia

To mark Rare Disease Day we will discuss some of the rarer causes of dementia, providing information about what causes them and how they can be diagnosed.


Celebrating the 5th anniversary of Join Dementia Research

Five years on from the national launch of Join Dementia Research, we look back at the service’s incredible impact and some of the exciting research taking place that you could get involved in.


How can wearables revolutionise the detection of dementia?

The Early Detection of Neurodegenerative diseases (EDoN) initiative is spearheaded by Alzheimer’s Research UK and brings together 14 leading research and support organisations, working to develop innovative ways to pick up these diseases in the brain years before the symptoms of dementia start.


How to guide: organise your own walk

It’s a fantastic way to fundraise and engage your local community.


Everything you need to know about PPA

Primary progressive aphasia (PPA) is a condition caused by damage to parts of the brain that control our personality, emotions, language and behaviour.

What we must see from the government’s ‘Dementia Moonshot’

It has certainly been a time of political turbulence. New governments bring new opportunities – and through its pledges, this one has given renewed hope to people affected by dementia. But we need more than hope: now we need action.


All you need to know about smoking and dementia

Most people know that smoking leads to poor health and a substantially increased risk of cancer and lung disease. But what’s the link to dementia?


‘We waited more than three years for an accurate diagnosis of Alzheimer’s’

This is our journey to a dementia diagnosis and illustrates why we need more research into quick and accurate diagnoses. It would’ve made such a difference to our lives.

Female researcher looks through microscope in lab.

Why is a lumbar puncture used in dementia?

Dr Cath Mummery aims to answer your questions about lumbar punctures, what the procedure involves and why it is used.


When would you want to know you had Alzheimer’s disease?

Would you want to know if you or a loved one had Alzheimer’s – a disease that currently has no treatments to slow, stop or prevent it – before you developed symptoms? This is understandably a frightening and tough question to answer.

Conservative government must act now to deliver their ‘Dementia Moonshot’

The votes have been cast, and the results are in: the Conservatives will form the UK’s next government. So what will this mean for dementia research?